ARTAN Bio is a biotechnology company developing gene therapies to address genetic and age-related diseases caused by nonsense mutations. It uses a suppressor tRNA system delivered via AAV9 vectors to restore protein function. Supported by VitaDAO’s decentralized funding, it conducts in vitro assays and animal studies to validate drug candidates for conditions like cancer and Alzheimer’s.
``
